- Home
- KRKR vs CNSP Comparison
KRKR vs CNSP Comparison
Compare KRKR & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRKR
- CNSP
- Stock Information
- Founded
- KRKR 2010
- CNSP 2017
- Country
- KRKR China
- CNSP United States
- Employees
- KRKR N/A
- CNSP N/A
- Industry
- KRKR Business Services
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- KRKR Consumer Discretionary
- CNSP Health Care
- Exchange
- KRKR Nasdaq
- CNSP Nasdaq
- Market Cap
- KRKR 6.6M
- CNSP 5.4M
- IPO Year
- KRKR 2019
- CNSP 2019
- Fundamental
- Price
- KRKR $3.22
- CNSP $0.11
- Analyst Decision
- KRKR
- CNSP Strong Buy
- Analyst Count
- KRKR 0
- CNSP 1
- Target Price
- KRKR N/A
- CNSP $0.50
- AVG Volume (30 Days)
- KRKR 22.3K
- CNSP 4.4M
- Earning Date
- KRKR 12-31-2024
- CNSP 11-15-2024
- Dividend Yield
- KRKR N/A
- CNSP N/A
- EPS Growth
- KRKR N/A
- CNSP N/A
- EPS
- KRKR N/A
- CNSP N/A
- Revenue
- KRKR $41,654,350.00
- CNSP N/A
- Revenue This Year
- KRKR $45.99
- CNSP N/A
- Revenue Next Year
- KRKR $31.46
- CNSP N/A
- P/E Ratio
- KRKR N/A
- CNSP N/A
- Revenue Growth
- KRKR N/A
- CNSP N/A
- 52 Week Low
- KRKR $2.76
- CNSP $0.10
- 52 Week High
- KRKR $12.60
- CNSP $70.00
- Technical
- Relative Strength Index (RSI)
- KRKR 52.25
- CNSP 49.71
- Support Level
- KRKR $3.10
- CNSP $0.10
- Resistance Level
- KRKR $3.69
- CNSP $0.12
- Average True Range (ATR)
- KRKR 0.35
- CNSP 0.01
- MACD
- KRKR 0.06
- CNSP 0.00
- Stochastic Oscillator
- KRKR 70.43
- CNSP 57.24
About KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.